Abstract
Purpose. The purpose of this study was to determine if lipid transfer protein (LTP I) facilitated triglyceride (TG) transfer activity regulates the plasma lipoprotein distribution of cyclosporine (CSA).
Methods. To assess the influence of drug concentration and incubation time on the plasma lipoprotein distribution of CSA, 3H-CSA (50 to 1000 ng/ml) was incubated in human plasma for 5 to 120 minutes at 37°C. To determine if LTP I facilitated TG transfer activity regulates the plasma lipoprotein distribution of CSA, 3H-Triolein (TG)- or 3H-CSA-enriched high-density lipoproteins (HDL) or low-density lipoproteins (LDL) were incubated in T150 buffer (50 mM Tris-HCl, 150 mM NaCl, 0.02% Sodium Azide, 0.01% Disodium EDTA), pH 7.4 which contained a 3H-Triolein (TG) or 3H-CSA-free lipoprotein counterpart ± exogenous LTP I (1.0 μg protein/ml) or in delipidated human plasma which contained 1.0 μg protein/ml of endogenous LTP I for 90 minutes at 37°C. These experiments were repeated in the presence of a monoclonal antibody TP1 (15 μg protein/ml) directed against LTP I.
Results. No differences in CSA lipoprotein distribution were observed following incubation of the drug at varying concentrations and incubation times in human plasma. The percent transfer of TG from HDL to LDL and LDL to HDL was greater in T150 buffer than in human plasma. However, the percent transfer of CSA from only LDL to HDL was greater in T150 buffer than in human plasma. Furthermore, undetectable 3H-CSA transfer from HDL to LDL in T150 buffer containing purified LTP I was observed. In addition, when the percent transfer of TG and CSA were determined in the presence of TP1, the percent transfer of TG and CSA from only LDL to HDL were significantly decreased in T150 buffer and human plasma compared to controls.
Conclusions. These findings suggest that the transfer of CSA between different lipoprotein particles is only partially influenced by LTP I facilitated TG transfer activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
A. R. Tall, E. Abreau, and J. Shuman. Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. J. Biol. Chem. 258:2174–2178 (1983).
R. E. Morton and D. B. Zilversmit. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J. Lipid Res. 23:1058–1067 (1982).
R. E. Morton and D. B. Zilversmit. Inter-relationships of lipid transferred by the lipid transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258:11751–11756 (1983).
R. E. Morton. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes. Experimentia 46:552–560 (1990).
O. V. Rajaram, G. H. White, and P. J. Barter. Partial purification and characterization of a triacylglycerol-transfer protein from rabbit serum. Biochim. Biophys. Acta. 617:383–390 (1980).
A. S. Jarnagin, W. Kohr, and C. Fielding. Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma. Proc. Natl. Acad. Sci. USA 84:1854–1860 (1987).
J. J. Albers, J. H. Tollefson, C-H Chen, and A. Steinmetz. Isolation and characterization of human lipid transfer proteins. Arteriosclerosis 4:49–58 (1984).
K. M. Wasan, M. Ramaswamy, W. Wong, and P. H. Pritchard. Lipid transfer protein I facilitated transfer of cyclosporine from low-to high-density lipoproteins is only partially dependent on its cholesteryl ester transfer activity. J. Pharmacol Exp. Ther. 284:599–605 (1998).
K. M. Wasan and S. M. Cassidy. Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. J. Pharm. Sci. 87:411–424 (1998).
K. M. Wasan, P. H. Pritchard, M. Ramaswamy, W. Wong, E. M. Donnachie, and L. J. Brunner. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine. Pharm. Res. 14:1613–1620 (1997).
J. Nemunaitis, H. J. Deeg, and G. C. Yee. High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridemia. Lancet i:744–745 (1986).
N. De Kippel, J. Sennesael, J. Lamote, G. Ebinger, and J. De Keyser. Cyclosporin leukoencephalopathy induced by intravenous lipid solution. Lancet 339:1114–1115 (1992).
P. C. de Groen, A. J. Aksamit, J. Rakela, G. S. Forbes, and R. A. F. From. Central nervous system toxicity after liver transplantation. N. Eng. J. Med. 317:861–866 (1987).
M. Lemaire, W. M. Pardridge, and G. Chaudhuri. Influence of blood components on the tissue uptake indices of cyclosporin in rats. J. Pharmacol. Exp. Ther. 244:740–743 (1988).
W. M. Pardridge. Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Invest. 64:145–154 (1979).
A. M. Gardier, D. Mathe, X. Guedeney, J. Barre, C. Benvenutti, N. Navarro, L. Vernillet, D. Loisance, J. P. Cachera, B. Jacotot, and J. P. Tillement. Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther. Drug Monit. 15:274–280 (1993).
M. Arnadottir, H. Thysell, and P. Nilsson-Ehle. Lipoprotein levels and post-heparin lipase activities in kidney transplant recipients: Ciclosporin-versus non-ciclosporin-treated patients. Am. J. Kidney Dis. 17:700–717 (1991).
P. Moulin, G. B. Appel, H. N. Ginsberg, and A. R. Tall. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. J. Lipid Res. 33:1817–1822 (1992).
M. Ramaswamy, X. Zhang, H. M. Burt, and K. M. Wasan. The human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. J. Pharm. Sci. 86:460–464 (1997).
R. J. Havel, H. A. Eder, and J. H. Bragdon. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345–1353 (1955).
K. M. Wasan, S. M. Cassidy, M. Ramaswamy, A. Kennedy, F. W. Strobel, S. P. Ng, and T. Y. Lee. A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine. Pharm. Res. 16:165–169 (1999).
M. Burstein, H. R. Scholnick, and R. Morfin. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11:583–595 (1970).
K. M. Wasan, R. E. Morton, M. G. Rosenblum, and G. Lopez-Berestein. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high density lipoproteins: Role of lipid transfer protein. J. Pharm. Sci. 83:1006–1010 (1994).
N. M. Pattnaik and D. B. Zilversmit. Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J. Biol. Chem. 254:2782–2786 (1979).
L. J. Brunner, D. R. Luke, J. Lautersztain, et al. Single-dose cyclosporine pharmacokinetics in various biological fluids of patients receiving allogenic bone marrow transplantation. Ther. Drug Monit. 12:134–138 (1990).
H. R. Betschart, W. R. Jondorf, and M. H. Bickel. Differences in adipose tissue distribution of basic lipophilic drugs between intraperitoneal and other routes of administration. Xenobiotica 18:113–121 (1988).
C. B. Hesler, A. R. Tall, T. L. Swenson, P. K. Weech, Y. L. Marcel, and R. W. Milne. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J. Biol. Chem. 263:5020–5023 (1988).
K. M. Wasan, G. A. Brazeau, A. Keyhani, A. C. Hayman, and G. Lopez-Berestein. Role of liposome composition and temperature on the distribution of amphotericin B in serum lipoproteins. Antimicrob. Agents Chemother. 37:246–250 (1993).
J. Bolard, M. Seigneuret, and G. Boudet. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B. Lipid State and cholesterol content dependence. Biochim. Biophys. Acta. 599:280–293 (1980).
D. Sgoutas, W. MacMahon, A. Love, and I. Jerkunica. Interaction of cyclosporine A with human lipoproteins. J. Pharm. Pharmacol. 38:583–588 (1986).
R. B. Shireman and J. F. Remsen. Imipramine associations with plasma components and its uptake by cultured human cells. Life Sci. 33:2165–2171 (1983).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wasan, K.M., Subramanian, R., Chou, J.WL. et al. Cyclosporine Transfer from Low- and High-Density Lipoproteins Is Partially Influenced by Lipid Transfer Protein I Triglyceride Transfer Activity. Pharm Res 16, 1067–1073 (1999). https://doi.org/10.1023/A:1018991917799
Issue Date:
DOI: https://doi.org/10.1023/A:1018991917799